Interferon‐alpha modulates the chemosensitivity of CD133‐expressing pancreatic cancer cells to gemcitabine

Pancreatic cancer is a lethal disease as current chemotherapies with gemcitabine (GEM) are still insufficient. Accumulating evidence suggests that cancer stem cells (CSC) are responsible for chemoresistance and that CD133 is one of the CSC markers in pancreatic cancer. Interferon‐alpha (IFN‐α), a cy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Hayashi, Tomomi, Ding, Qiang, Kuwahata, Taisaku, Maeda, Koki, Miyazaki, Yumi, Matsubara, Shuichiro, Obara, Toru, Natsugoe, Shoji, Takao, Sonshin
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2012
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659312/
https://ncbi.nlm.nih.gov/pubmed/22320450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2012.02235.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados